Re: The Price of Pharmaceuticals (+ the slowness of Scott Speed)
From: ken rentiers (rentiersmac.com)
Date: Fri, 11 May 2007 15:00:13 -0700 (PDT)
Steve at al:

I completely agree that propping up sundry socialist medical schemes by burdening the American taxpayer with all the R&D costs stinks. But government intervention is a poor solution.

Example: as we speak Congress has busied itself with enacting a prohibition against the importation of foreign prescription drugs by the consumer. This will only raise US drug prices. If American consumers are free to buy whatever they need wherever it is cheapest, those manufacturing said pharmaceuticals will soon abandon tiered pricing based on national boundaries and allocate their costs globally. Further if certain countries ignore our pharmaceutical patents, the pharmaceutical manufacturer affected can always cut off new shipments of any and all drugs made to that region.

The marketplace beats regulation every time. We should rip down any restraints on international commerce in prescription drugs, not the reverse.

Just my $0.02 worth.

ken

Obligatory F1 content: is Scott Speed in danger of unemployment?




On May 11, 2007, at 4:19 PM, BRIGANDBAR [at] aol.com wrote:

Ken is correct that the actual cost of producing a unit of a medication is
only a nominal cost of the drug itself for the reasons that he has clearly
articulated.


I would, however, question why the patient in the U.S. is expected to
subsidize the socialized medical programs of the rest of the first world, as well
as patients in the third world. There is absolutely no reason why the costs
detailed by Ken should not be fairly distributed amongst all of the end users of
the world, first and third. And the simple, while I generally eschew
government intervention it is justified in this instance because other governmental
entities are intervening to create artificially low prices in their
nations/markets.


This simple solution would be to place an export duty on all pharmaceuticals
exported or produced under license from the United States equal to 200% of
the differential between the mean price in the U.S. and the price to be paid
by the purchaser nation. Perhaps more simply explained by example, if Canada
pays one dollar per dosage unit for a specific pharmaceutical while the mean
price in the U.S. is five dollars per dosage unit then the export duty would
be eight dollars ($5.00-$1.00=$4.00 x 2 = $8.00). This would result in a cost
to Canada of nine dollars per dosage unit. Of course, it might be preferable
to price this pharmaceutical uniformly at say three dollars per dosage unit
eliminating any export duty yet resulting in a price to the producer of six
dollars for two dosage units, precisely what they are receiving under the
current price model in the example. And, the price would be uniform for both
Canadians and Americans and each would contribute fairly for the fixed cost of the
pharmaceutical at time of production, including an amortized cost of
research and development.


Of course this is an oversimplification of the economics of medicine and
pharmacy, but it is only submitted as an example of what could be done using
similar numbers and pricing structures. The bottom line would be that American
consumers would not be subsidizing the socialist world in the venue of health.


Dr. Steve

1964 Rolls  Royce Silver Cloud III    1975 Pontiac GV Conv.
1980 MB  450SL                 1982 RR  Corniche
1988 Rolls Royce Silver  Spur         1994 F-350 Powerstroke  4x4
1996  Bronco                                  2000 Lincoln Town Car
1995 Ferrari 348  Spyder                 2004 Excursion
+ Audrey's 2x MB's

Dr. Stephen B. Spies, CES,  CFI
Director, Forensic Sciences Laboratory
Explosives Engineering  Technologies

Legal Notice:

This message does not constitute legal or other professional advice, nor
does it create an Attorney/Client, or other confidential or fiduciary
relationship between the sender and/or any other party


Confidentiality Notice: This e-mail (including attachments) is covered by
the Electronic Communications Privacy Act, 18 U. S. C., Sections 2510-2521, and
is intended only for the person or entity to which it is addressed, and may
contain confidential or privileged material. Any unauthorized review, use,
disclosure, dissemination, copying, forwarding or distribution is prohibited.
If you are not the intended recipient contact the sender by reply e-mail and
destroy all copies of the original message. If you are the intended recipient
but do not wish to receive communications through this medium please so
advise the sender immediately.


Electronic Transmission Security Notice: E-mail transmission cannot be
guaranteed to be secure or error-free. The sender does not accept liability for
any errors or omissions in the contents of the message that arises as a result
of its electronic (e-mail) transmission.




************************************** See what's free at http:// www.aol.com.
_________________________________________________________________
To unsubscribe or modify your subscription options, please visit:
http://lists.ferrarilist.com/mailman/options/ferrari/rentiers% 40mail.com


Sponsored by BidNip.com eBay Auction Sniper
http://www.BidNip.com/
and F1 Headlines
http://www.F1Headlines.com/

Results generated by Tiger Technologies Web hosting using MHonArc.